HEADER HYDROLASE 02-SEP-09 3IWM TITLE THE OCTAMERIC SARS-COV MAIN PROTEASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: 3CL-PRO, 3CLP; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~- COMPND 9 ((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3- COMPND 10 YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE; COMPND 11 CHAIN: H, F, G, E; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SARS CORONAVIRUS; SOURCE 3 ORGANISM_COMMON: SARS-COV; SOURCE 4 ORGANISM_TAXID: 227859; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 ROSETTA(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-28A; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 13 ORGANISM_TAXID: 32630 KEYWDS SARS-COV, MAIN PROTEASE, OCTAMER, ACTIVE CONFORMATION, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR N.ZHONG,S.ZHANG,F.XUE,Z.LOU,Z.RAO,B.XIA REVDAT 5 15-NOV-23 3IWM 1 LINK ATOM REVDAT 4 01-NOV-23 3IWM 1 LINK REVDAT 3 09-DEC-15 3IWM 1 ATOM COMPND HETATM REMARK REVDAT 3 2 1 SEQRES REVDAT 2 28-MAR-12 3IWM 1 JRNL VERSN REVDAT 1 21-JUL-10 3IWM 0 JRNL AUTH S.ZHANG,N.ZHONG,F.XUE,X.KANG,X.REN,J.CHEN,C.JIN,Z.LOU,B.XIA JRNL TITL THREE-DIMENSIONAL DOMAIN SWAPPING AS A MECHANISM TO LOCK THE JRNL TITL 2 ACTIVE CONFORMATION IN A SUPER-ACTIVE OCTAMER OF SARS-COV JRNL TITL 3 MAIN PROTEASE JRNL REF PROTEIN CELL V. 1 371 2010 JRNL REFN ISSN 1674-800X JRNL PMID 21203949 JRNL DOI 10.1007/S13238-010-0044-8 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.94 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 3 NUMBER OF REFLECTIONS : 33573 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1771 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.9480 - 7.5160 1.00 2926 142 0.2120 0.2640 REMARK 3 2 7.5160 - 5.9690 1.00 2760 158 0.2070 0.2410 REMARK 3 3 5.9690 - 5.2150 1.00 2726 151 0.2050 0.2640 REMARK 3 4 5.2150 - 4.7390 1.00 2717 143 0.1800 0.2420 REMARK 3 5 4.7390 - 4.4000 1.00 2711 134 0.1800 0.2370 REMARK 3 6 4.4000 - 4.1400 1.00 2685 156 0.1890 0.2290 REMARK 3 7 4.1400 - 3.9330 1.00 2680 142 0.1970 0.2300 REMARK 3 8 3.9330 - 3.7620 1.00 2699 133 0.2260 0.2770 REMARK 3 9 3.7620 - 3.6170 1.00 2646 160 0.2380 0.2990 REMARK 3 10 3.6170 - 3.4920 1.00 2654 152 0.2580 0.3230 REMARK 3 11 3.4920 - 3.3830 0.94 2506 129 0.2840 0.3780 REMARK 3 12 3.3830 - 3.2860 0.77 2068 100 0.3290 0.3680 REMARK 3 13 3.2860 - 3.2000 0.52 1370 71 0.3490 0.3730 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.37 REMARK 3 B_SOL : 79.99 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.070 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 97.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 86.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.03300 REMARK 3 B22 (A**2) : 9.03300 REMARK 3 B33 (A**2) : -4.90600 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 9728 REMARK 3 ANGLE : 1.526 13216 REMARK 3 CHIRALITY : 0.104 1462 REMARK 3 PLANARITY : 0.021 1702 REMARK 3 DIHEDRAL : 23.541 3556 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3IWM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-SEP-09. REMARK 100 THE DEPOSITION ID IS D_1000054956. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 270 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33573 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 22.60 REMARK 200 R MERGE (I) : 0.15500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 64.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.65200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2HOB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM CHLORIDE, 0.1M BIS-TRIS REMARK 280 (PH 5.5) AND 25% W/V PEG 3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 83.21750 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 80.96500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 80.96500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 41.60875 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 80.96500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 80.96500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 124.82625 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 80.96500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 80.96500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 41.60875 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 80.96500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 80.96500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 124.82625 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 83.21750 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXADECAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXADECAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 55270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 95180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -353.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, H, F, G, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)- REMARK 400 4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL) REMARK 400 -L-LEUCINAMIDE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R, REMARK 400 2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL] REMARK 400 METHYL}BUT-2-ENYL)-L-LEUCINAMIDE REMARK 400 CHAIN: H, F, G, E REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 302 REMARK 465 VAL A 303 REMARK 465 THR A 304 REMARK 465 PHE A 305 REMARK 465 GLN A 306 REMARK 465 GLY B 302 REMARK 465 VAL B 303 REMARK 465 THR B 304 REMARK 465 PHE B 305 REMARK 465 GLN B 306 REMARK 465 SER C 301 REMARK 465 GLY C 302 REMARK 465 VAL C 303 REMARK 465 THR C 304 REMARK 465 PHE C 305 REMARK 465 GLN C 306 REMARK 465 SER D 301 REMARK 465 GLY D 302 REMARK 465 VAL D 303 REMARK 465 THR D 304 REMARK 465 PHE D 305 REMARK 465 GLN D 306 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ARG C 40 N VAL C 42 2.00 REMARK 500 O TYR D 154 N CYS D 156 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LEU H 4 C PJE H 5 N 0.145 REMARK 500 LEU F 4 C PJE F 5 N 0.148 REMARK 500 VAL G 3 C LEU G 4 N 0.140 REMARK 500 LEU E 4 C PJE E 5 N 0.141 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 122 C - N - CA ANGL. DEV. = 11.4 DEGREES REMARK 500 PRO C 252 C - N - CA ANGL. DEV. = 12.0 DEGREES REMARK 500 ILE D 59 N - CA - C ANGL. DEV. = -17.0 DEGREES REMARK 500 ALA H 2 C - N - CA ANGL. DEV. = -16.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 22 57.84 -109.95 REMARK 500 THR A 24 -51.32 107.54 REMARK 500 ASP A 33 -112.50 53.52 REMARK 500 ALA A 46 35.03 -61.48 REMARK 500 LEU A 50 -36.77 -31.57 REMARK 500 ASN A 51 81.46 162.76 REMARK 500 ASN A 72 -73.85 -123.42 REMARK 500 VAL A 73 55.06 19.38 REMARK 500 ASN A 84 -78.69 70.26 REMARK 500 LEU A 89 99.36 51.33 REMARK 500 ASN A 95 109.89 -50.71 REMARK 500 PHE A 103 55.49 -104.22 REMARK 500 ILE A 106 163.57 -31.59 REMARK 500 LEU A 115 73.99 -118.27 REMARK 500 ASN A 119 67.56 36.31 REMARK 500 PRO A 122 -119.27 1.21 REMARK 500 SER A 123 -54.65 104.26 REMARK 500 ARG A 131 161.98 -47.79 REMARK 500 HIS A 134 -0.40 100.98 REMARK 500 TYR A 154 -150.12 54.43 REMARK 500 HIS A 164 -65.06 -109.14 REMARK 500 GLN A 189 26.39 -74.55 REMARK 500 ALA A 191 87.17 -45.72 REMARK 500 ASP A 197 -94.33 -77.58 REMARK 500 THR A 198 139.13 90.35 REMARK 500 ASN A 221 89.88 -52.05 REMARK 500 PHE A 223 -84.51 116.74 REMARK 500 THR A 224 160.39 51.14 REMARK 500 PRO A 241 112.05 -29.15 REMARK 500 ALA A 255 -77.94 -69.62 REMARK 500 VAL A 261 -65.20 -8.46 REMARK 500 LYS A 269 13.05 -66.81 REMARK 500 GLU A 270 -1.45 168.45 REMARK 500 ASN A 277 86.91 45.48 REMARK 500 CYS A 300 131.35 -171.66 REMARK 500 PHE B 3 100.98 -160.74 REMARK 500 PRO B 9 106.65 -42.17 REMARK 500 THR B 24 -48.99 67.33 REMARK 500 ASP B 33 -89.71 39.56 REMARK 500 ASP B 34 35.26 -140.06 REMARK 500 ARG B 40 -141.38 -60.68 REMARK 500 HIS B 41 -2.46 41.54 REMARK 500 THR B 45 -19.27 -140.25 REMARK 500 ALA B 46 7.94 95.01 REMARK 500 ASP B 56 -40.43 87.34 REMARK 500 ILE B 59 138.98 81.17 REMARK 500 ARG B 60 -39.38 89.28 REMARK 500 ASN B 63 -8.84 -53.49 REMARK 500 GLN B 83 25.19 -144.56 REMARK 500 ASN B 84 -56.21 124.64 REMARK 500 REMARK 500 THIS ENTRY HAS 165 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 71 ASN A 72 146.93 REMARK 500 PHE A 223 THR A 224 -148.98 REMARK 500 ILE B 59 ARG B 60 -144.01 REMARK 500 ARG B 222 PHE B 223 108.00 REMARK 500 LEU C 50 ASN C 51 148.33 REMARK 500 ILE C 59 ARG C 60 144.40 REMARK 500 LEU D 58 ILE D 59 121.22 REMARK 500 VAL G 3 LEU G 4 132.83 REMARK 500 LEU G 4 PJE G 5 54.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ALA H 2 14.08 REMARK 500 ALA F 2 10.84 REMARK 500 VAL F 3 -14.41 REMARK 500 LEU G 4 20.49 REMARK 500 ALA E 2 -17.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN H OF N-[(5-METHYLISOXAZOL REMARK 800 -3-YL)CARBONYL]ALANYL-L-VALYL-N~1~- ((1R,2Z)-4-(BENZYLOXY)-4-OXO- REMARK 800 1-{[(3R)-2-OXOPYRROLIDIN-3- YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF N-[(5-METHYLISOXAZOL REMARK 800 -3-YL)CARBONYL]ALANYL-L-VALYL-N~1~- ((1R,2Z)-4-(BENZYLOXY)-4-OXO- REMARK 800 1-{[(3R)-2-OXOPYRROLIDIN-3- YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN G OF N-[(5-METHYLISOXAZOL REMARK 800 -3-YL)CARBONYL]ALANYL-L-VALYL-N~1~- ((1R,2Z)-4-(BENZYLOXY)-4-OXO- REMARK 800 1-{[(3R)-2-OXOPYRROLIDIN-3- YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF N-[(5-METHYLISOXAZOL REMARK 800 -3-YL)CARBONYL]ALANYL-L-VALYL-N~1~- ((1R,2Z)-4-(BENZYLOXY)-4-OXO- REMARK 800 1-{[(3R)-2-OXOPYRROLIDIN-3- YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE DBREF 3IWM A 1 306 UNP P0C6U8 R1A_CVHSA 3241 3546 DBREF 3IWM B 1 306 UNP P0C6U8 R1A_CVHSA 3241 3546 DBREF 3IWM C 1 306 UNP P0C6U8 R1A_CVHSA 3241 3546 DBREF 3IWM D 1 306 UNP P0C6U8 R1A_CVHSA 3241 3546 DBREF 3IWM E 1 6 PDB 3IWM 3IWM 1 6 DBREF 3IWM F 1 6 PDB 3IWM 3IWM 1 6 DBREF 3IWM G 1 6 PDB 3IWM 3IWM 1 6 DBREF 3IWM H 1 6 PDB 3IWM 3IWM 1 6 SEQRES 1 A 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 A 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 A 306 LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS PRO SEQRES 4 A 306 ARG HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN PRO SEQRES 5 A 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SER SEQRES 6 A 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 A 306 GLY HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS VAL SEQRES 8 A 306 ASP THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 A 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 A 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 A 306 ARG PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 A 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 A 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 A 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE TYR SEQRES 15 A 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 A 306 THR ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP LEU SEQRES 17 A 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 A 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 A 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 A 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 A 306 VAL LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU GLN SEQRES 22 A 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER THR ILE SEQRES 23 A 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 A 306 CYS SER GLY VAL THR PHE GLN SEQRES 1 B 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 B 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 B 306 LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS PRO SEQRES 4 B 306 ARG HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN PRO SEQRES 5 B 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SER SEQRES 6 B 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 B 306 GLY HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS VAL SEQRES 8 B 306 ASP THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 B 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 B 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 B 306 ARG PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 B 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 B 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 B 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE TYR SEQRES 15 B 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 B 306 THR ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP LEU SEQRES 17 B 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 B 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 B 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 B 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 B 306 VAL LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU GLN SEQRES 22 B 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER THR ILE SEQRES 23 B 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 B 306 CYS SER GLY VAL THR PHE GLN SEQRES 1 C 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 C 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 C 306 LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS PRO SEQRES 4 C 306 ARG HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN PRO SEQRES 5 C 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SER SEQRES 6 C 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 C 306 GLY HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS VAL SEQRES 8 C 306 ASP THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 C 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 C 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 C 306 ARG PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 C 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 C 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 C 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE TYR SEQRES 15 C 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 C 306 THR ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP LEU SEQRES 17 C 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 C 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 C 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 C 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 C 306 VAL LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU GLN SEQRES 22 C 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER THR ILE SEQRES 23 C 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 C 306 CYS SER GLY VAL THR PHE GLN SEQRES 1 D 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 D 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 D 306 LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS PRO SEQRES 4 D 306 ARG HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN PRO SEQRES 5 D 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SER SEQRES 6 D 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 D 306 GLY HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS VAL SEQRES 8 D 306 ASP THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 D 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 D 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 D 306 ARG PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 D 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 D 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 D 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE TYR SEQRES 15 D 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 D 306 THR ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP LEU SEQRES 17 D 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 D 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 D 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 D 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 D 306 VAL LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU GLN SEQRES 22 D 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER THR ILE SEQRES 23 D 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 D 306 CYS SER GLY VAL THR PHE GLN SEQRES 1 H 6 02J ALA VAL LEU PJE 010 SEQRES 1 F 6 02J ALA VAL LEU PJE 010 SEQRES 1 G 6 02J ALA VAL LEU PJE 010 SEQRES 1 E 6 02J ALA VAL LEU PJE 010 HET 02J H 1 8 HET PJE H 5 13 HET 010 H 6 8 HET 02J F 1 8 HET PJE F 5 13 HET 010 F 6 8 HET 02J G 1 8 HET PJE G 5 13 HET 010 G 6 8 HET 02J E 1 8 HET PJE E 5 13 HET 010 E 6 8 HETNAM 02J 5-METHYL-1,2-OXAZOLE-3-CARBOXYLIC ACID HETNAM PJE (E,4S)-4-AZANYL-5-[(3S)-2-OXIDANYLIDENEPYRROLIDIN-3- HETNAM 2 PJE YL]PENT-2-ENOIC ACID HETNAM 010 PHENYLMETHANOL FORMUL 5 02J 4(C5 H5 N O3) FORMUL 5 PJE 4(C9 H14 N2 O3) FORMUL 5 010 4(C7 H8 O) HELIX 1 1 SER A 10 GLY A 15 1 6 HELIX 2 2 HIS A 41 ILE A 43 5 3 HELIX 3 3 ASN A 53 ILE A 59 1 7 HELIX 4 4 THR A 201 ASN A 214 1 14 HELIX 5 5 THR A 226 TYR A 237 1 12 HELIX 6 6 THR A 243 THR A 257 1 15 HELIX 7 7 ALA A 260 LYS A 269 1 10 HELIX 8 8 GLU A 270 GLY A 275 1 6 HELIX 9 9 THR A 292 GLN A 299 1 8 HELIX 10 10 SER B 10 GLY B 15 1 6 HELIX 11 11 ASN B 53 LEU B 58 1 6 HELIX 12 12 ILE B 200 ILE B 213 1 14 HELIX 13 13 THR B 226 TYR B 237 1 12 HELIX 14 14 THR B 243 THR B 257 1 15 HELIX 15 15 ALA B 260 GLN B 273 1 14 HELIX 16 16 THR B 280 SER B 284 5 5 HELIX 17 17 THR B 292 CYS B 300 1 9 HELIX 18 18 SER C 10 GLY C 15 1 6 HELIX 19 19 SER C 62 PHE C 66 5 5 HELIX 20 20 ILE C 200 ASN C 214 1 15 HELIX 21 21 ARG C 217 ASN C 221 5 5 HELIX 22 22 PHE C 230 LEU C 232 5 3 HELIX 23 23 VAL C 233 ASN C 238 1 6 HELIX 24 24 THR C 243 GLY C 258 1 16 HELIX 25 25 ALA C 260 GLN C 273 1 14 HELIX 26 26 PHE C 294 CYS C 300 1 7 HELIX 27 27 SER D 10 GLY D 15 1 6 HELIX 28 28 ILE D 200 ASN D 214 1 15 HELIX 29 29 THR D 226 MET D 235 1 10 HELIX 30 30 THR D 243 GLY D 258 1 16 HELIX 31 31 ALA D 260 GLY D 275 1 16 HELIX 32 32 THR D 292 GLN D 299 1 8 SHEET 1 A 5 MET A 17 THR A 21 0 SHEET 2 A 5 THR A 26 LEU A 32 -1 O GLY A 29 N VAL A 18 SHEET 3 A 5 THR A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 4 A 5 LEU A 86 LEU A 87 -1 O LEU A 87 N CYS A 38 SHEET 5 A 5 MET A 82 GLN A 83 -1 O GLN A 83 N LEU A 86 SHEET 1 B 5 TYR A 101 LYS A 102 0 SHEET 2 B 5 CYS A 156 HIS A 163 1 O VAL A 157 N LYS A 102 SHEET 3 B 5 VAL A 148 ASP A 153 -1 N GLY A 149 O TYR A 161 SHEET 4 B 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 B 5 SER A 121 ALA A 129 -1 O TYR A 126 N VAL A 114 SHEET 1 C 3 TYR A 101 LYS A 102 0 SHEET 2 C 3 CYS A 156 HIS A 163 1 O VAL A 157 N LYS A 102 SHEET 3 C 3 GLY A 174 THR A 175 -1 O THR A 175 N MET A 162 SHEET 1 D 7 MET B 17 THR B 21 0 SHEET 2 D 7 THR B 26 LEU B 32 -1 O GLY B 29 N VAL B 18 SHEET 3 D 7 THR B 35 TYR B 37 -1 O THR B 35 N LEU B 32 SHEET 4 D 7 LEU B 87 VAL B 91 -1 O LEU B 89 N VAL B 36 SHEET 5 D 7 VAL B 73 MET B 82 -1 N SER B 81 O ARG B 88 SHEET 6 D 7 LEU B 67 ALA B 70 -1 N ALA B 70 O VAL B 73 SHEET 7 D 7 MET B 17 THR B 21 -1 N GLN B 19 O GLN B 69 SHEET 1 E 3 LYS B 100 PHE B 103 0 SHEET 2 E 3 CYS B 156 PHE B 159 1 O VAL B 157 N LYS B 100 SHEET 3 E 3 ILE B 152 ASP B 153 -1 N ASP B 153 O CYS B 156 SHEET 1 F 5 SER B 121 CYS B 128 0 SHEET 2 F 5 PHE B 112 TYR B 118 -1 N ALA B 116 O SER B 123 SHEET 3 F 5 VAL B 148 PHE B 150 -1 O PHE B 150 N SER B 113 SHEET 4 F 5 TYR B 161 MET B 165 -1 O TYR B 161 N GLY B 149 SHEET 5 F 5 ALA B 173 THR B 175 -1 O THR B 175 N MET B 162 SHEET 1 G 7 VAL C 73 LEU C 75 0 SHEET 2 G 7 LEU C 67 ALA C 70 -1 N VAL C 68 O LEU C 75 SHEET 3 G 7 MET C 17 THR C 21 -1 N THR C 21 O LEU C 67 SHEET 4 G 7 THR C 26 LEU C 32 -1 O GLY C 29 N VAL C 18 SHEET 5 G 7 THR C 35 TYR C 37 -1 O TYR C 37 N LEU C 30 SHEET 6 G 7 LEU C 86 LYS C 90 -1 O LEU C 89 N VAL C 36 SHEET 7 G 7 HIS C 80 GLN C 83 -1 N GLN C 83 O LEU C 86 SHEET 1 H 5 TYR C 101 PHE C 103 0 SHEET 2 H 5 VAL C 157 GLU C 166 1 O VAL C 157 N LYS C 102 SHEET 3 H 5 VAL C 148 ASN C 151 -1 N GLY C 149 O TYR C 161 SHEET 4 H 5 THR C 111 TYR C 118 -1 N SER C 113 O PHE C 150 SHEET 5 H 5 SER C 121 ALA C 129 -1 O TYR C 126 N VAL C 114 SHEET 1 I 3 TYR C 101 PHE C 103 0 SHEET 2 I 3 VAL C 157 GLU C 166 1 O VAL C 157 N LYS C 102 SHEET 3 I 3 HIS C 172 THR C 175 -1 O THR C 175 N MET C 162 SHEET 1 J 2 MET D 17 VAL D 18 0 SHEET 2 J 2 GLY D 29 LEU D 30 -1 O GLY D 29 N VAL D 18 SHEET 1 K 2 THR D 21 CYS D 22 0 SHEET 2 K 2 THR D 25 THR D 26 -1 O THR D 25 N CYS D 22 SHEET 1 L 2 GLN D 69 ALA D 70 0 SHEET 2 L 2 VAL D 73 GLN D 74 -1 O VAL D 73 N ALA D 70 SHEET 1 M 5 PRO D 122 TYR D 126 0 SHEET 2 M 5 SER D 113 CYS D 117 -1 N VAL D 114 O TYR D 126 SHEET 3 M 5 VAL D 148 PHE D 150 -1 O PHE D 150 N SER D 113 SHEET 4 M 5 TYR D 161 MET D 165 -1 O TYR D 161 N GLY D 149 SHEET 5 M 5 ALA D 173 THR D 175 -1 O ALA D 173 N MET D 165 LINK C 02J H 1 N ALA H 2 1555 1555 1.47 LINK C LEU H 4 N PJE H 5 1555 1555 1.48 LINK C PJE H 5 O 010 H 6 1555 1555 1.42 LINK C 02J F 1 N ALA F 2 1555 1555 1.46 LINK C LEU F 4 N PJE F 5 1555 1555 1.48 LINK C PJE F 5 O 010 F 6 1555 1555 1.41 LINK C 02J G 1 N ALA G 2 1555 1555 1.45 LINK C LEU G 4 N PJE G 5 1555 1555 1.45 LINK C PJE G 5 O 010 G 6 1555 1555 1.40 LINK C 02J E 1 N ALA E 2 1555 1555 1.47 LINK C LEU E 4 N PJE E 5 1555 1555 1.48 LINK C PJE E 5 O 010 E 6 1555 1555 1.42 SITE 1 AC1 19 THR A 25 THR A 26 LEU A 27 HIS A 41 SITE 2 AC1 19 PHE A 140 LEU A 141 ASN A 142 GLY A 143 SITE 3 AC1 19 CYS A 145 HIS A 163 HIS A 164 MET A 165 SITE 4 AC1 19 GLU A 166 PRO A 168 ASP A 187 ARG A 188 SITE 5 AC1 19 GLN A 189 THR A 190 ALA A 191 SITE 1 AC2 15 THR B 25 HIS B 41 PHE B 140 ASN B 142 SITE 2 AC2 15 GLY B 143 CYS B 145 HIS B 163 HIS B 164 SITE 3 AC2 15 MET B 165 GLU B 166 PRO B 168 GLN B 189 SITE 4 AC2 15 THR B 190 GLN B 192 THR C 24 SITE 1 AC3 18 THR B 24 LEU C 27 HIS C 41 MET C 49 SITE 2 AC3 18 PHE C 140 ASN C 142 GLY C 143 CYS C 145 SITE 3 AC3 18 HIS C 163 HIS C 164 MET C 165 GLU C 166 SITE 4 AC3 18 LEU C 167 PRO C 168 ARG C 188 GLN C 189 SITE 5 AC3 18 THR C 190 ALA C 191 SITE 1 AC4 19 THR D 26 HIS D 41 PHE D 140 LEU D 141 SITE 2 AC4 19 ASN D 142 GLY D 143 CYS D 145 HIS D 163 SITE 3 AC4 19 HIS D 164 MET D 165 GLU D 166 LEU D 167 SITE 4 AC4 19 PRO D 168 ASP D 187 ARG D 188 GLN D 189 SITE 5 AC4 19 THR D 190 ALA D 191 GLN D 192 CRYST1 161.930 161.930 166.435 90.00 90.00 90.00 P 41 21 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006176 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006176 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006008 0.00000